Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases.

Press/Media

Period18 Jan 2019

Media coverage

1

Media coverage

  • TitleMount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases.
    Media name/outletPRWeb Newswire
    Country/TerritoryUnited States
    Date18/01/19
    PersonsCalogera Simonaro, Edward Schuchman